Shin Young Hyun
Overview
Explore the profile of Shin Young Hyun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim D, Kim Y, Suh C, Yoon D, Yang D, Park Y, et al.
Am J Gastroenterol
. 2023 Feb;
118(8):1373-1380.
PMID: 36728217
Introduction: This prospective study aimed to investigate the efficacy and safety of preemptive antiviral therapy with tenofovir disoproxil fumarate (TDF) for HBsAg-positive patients with newly diagnosed diffuse large B-cell lymphoma...
2.
Jeong S, Kim S, Yoon D, Park Y, Kang H, Koh Y, et al.
Cancer Res Treat
. 2022 Jan;
54(4):1268-1277.
PMID: 34990525
Purpose: Febrile neutropenia (FN) can cause suboptimal treatment and treatment-related mortality (TRM) in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). Materials And...
3.
Hong J, Lee Y, Bae S, Yi J, Park S, Chang M, et al.
Blood Res
. 2021 Jun;
56(2):102-108.
PMID: 34187943
Background: To estimate real-world outcomes in East Asian populations, we conducted a nationwide retrospective analysis of the efficacy and safety of lenalidomide for del(5q) myelodysplastic syndrome (MDS) patients with transfusion-dependent...
4.
Hyun S, Shin H, Yoon S, Moon J, Han J, Yang D, et al.
Haemophilia
. 2021 Jun;
27(5):e609-e616.
PMID: 34156738
Introduction: Acquired haemophilia A (AHA) treatment involves the haemostatic treatment for acute haemorrhage and immunosuppressive therapy (IST) to eradicate FVIII inhibitory antibodies. Aim: We assessed the clinical features of AHA...
5.
Yi J, Kim S, Yoon D, Suh C, Chang M, Yang D, et al.
Cancer Commun (Lond)
. 2021 Feb;
41(3):275-278.
PMID: 33626235
No abstract available.
6.
Jeong S, Hyun S, Choi J, Kim H
J Korean Med Sci
. 2020 Sep;
35(36):e294.
PMID: 32924338
Background: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma) is an extranodal lymphoma that occurs at various sites in the body. There is a limited understanding of the...
7.
Hyun S, Na E, Jang J, Chung H, Kim S, Kim J, et al.
Cancer Med
. 2020 Aug;
9(19):7007-7017.
PMID: 32780544
Objective: Myeloid-derived suppressor cells (MDSCs) facilitate tumor growth and development by suppressing T cell function; however, their role in acute myeloid leukemia (AML) remains unclear. Here, we investigated the immunosuppressive...
8.
Kong J, Nam H, Go T, Hyun S, Shim K
Blood Res
. 2019 Nov;
54(3):233-236.
PMID: 31730680
No abstract available.
9.
Seo H, Ko T, Hyun S, Song H, Lim S, Shim K, et al.
Clin Lymphoma Myeloma Leuk
. 2019 Sep;
19(11):735-743.e2.
PMID: 31563565
Introduction: Tyrosine kinase inhibitors (TKIs) improve the survival rate of patients with chronic myeloid leukemia (CML). However, elderly patients often experience adverse events and require dose adjustments, leading to dose...
10.
Hyun S, Na E, Jang J, Chung H, Kim S, Kim J, et al.
Biochem Biophys Res Commun
. 2019 Sep;
519(4):887-893.
PMID: 31561854
We investigated the effect of the modulation of Na/H exchanger 1 (NHE1) on apoptosis, differentiation, and chemoresistance in acute myeloid leukemia (AML) cells to evaluate the possibility of NHE1 modulation...